Karin Botha

Karin Botha currently works at Matting AB, as Director, Matting Holding AB, as Director, Sybo invest AB, as Director, and Disruptive Pharma AB, as Chief Financial Officer from 2026.
Ms. Botha also formerly worked at Novartis Healthcare A, as Director, Novartis Sverige AB, as Head-Financial Controls & Compliance Nordic from 2015 to 2020, and Guard Therapeutics International AB, as Chief Financial Officer.
Ms. Botha received her graduate degree from the University of Gothenburg.